Cargando…

An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants

The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Tallei, Trina Ekawati, Fatimawali, Yelnetty, Afriza, Idroes, Rinaldi, Kusumawaty, Diah, Emran, Talha Bin, Yesiloglu, Talha Zahid, Sippl, Wolfgang, Mahmud, Shafi, Alqahtani, Taha, Alqahtani, Ali M., Asiri, Saeed, Rahmatullah, Mohammed, Jahan, Rownak, Khan, Md. Arif, Celik, Ismail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417730/
https://www.ncbi.nlm.nih.gov/pubmed/34489706
http://dx.doi.org/10.3389/fphar.2021.717757
_version_ 1783748440622104576
author Tallei, Trina Ekawati
Fatimawali,
Yelnetty, Afriza
Idroes, Rinaldi
Kusumawaty, Diah
Emran, Talha Bin
Yesiloglu, Talha Zahid
Sippl, Wolfgang
Mahmud, Shafi
Alqahtani, Taha
Alqahtani, Ali M.
Asiri, Saeed
Rahmatullah, Mohammed
Jahan, Rownak
Khan, Md. Arif
Celik, Ismail
author_facet Tallei, Trina Ekawati
Fatimawali,
Yelnetty, Afriza
Idroes, Rinaldi
Kusumawaty, Diah
Emran, Talha Bin
Yesiloglu, Talha Zahid
Sippl, Wolfgang
Mahmud, Shafi
Alqahtani, Taha
Alqahtani, Ali M.
Asiri, Saeed
Rahmatullah, Mohammed
Jahan, Rownak
Khan, Md. Arif
Celik, Ismail
author_sort Tallei, Trina Ekawati
collection PubMed
description The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as well as several other important parts of this virus, have recently undergone mutations, resulting in new virus variants. While no treatment is currently available, a naturally derived molecule with known antiviral properties could be used as a potential treatment. Bromelain is an enzyme found in the fruit and stem of pineapples. This substance has been shown to have a broad antiviral activity. In this article, we analyse the ability of bromelain to counteract various variants of the SARS-CoV-2 by targeting bromelain binding on the side of this viral interaction with human angiotensin-converting enzyme 2 (hACE2) using molecular docking and molecular dynamics simulation approaches. We have succeeded in making three-dimensional configurations of various RBD variants using protein modelling. Bromelain exhibited good binding affinity toward various variants of RBDs and binds right at the binding site between RBDs and hACE2. This result is also presented in the modelling between Bromelain, RBD, and hACE2. The molecular dynamics (MD) simulations study revealed significant stability of the bromelain and RBD proteins separately up to 100 ns with an RMSD value of 2 Å. Furthermore, despite increases in RMSD and changes in Rog values of complexes, which are likely due to some destabilized interactions between bromelain and RBD proteins, two proteins in each complex remained bonded, and the site where the two proteins bind remained unchanged. This finding indicated that bromelain could have an inhibitory effect on different SARS-CoV-2 variants, paving the way for a new SARS-CoV-2 inhibitor drug. However, more in vitro and in vivo research on this potential mechanism of action is required.
format Online
Article
Text
id pubmed-8417730
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84177302021-09-05 An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants Tallei, Trina Ekawati Fatimawali, Yelnetty, Afriza Idroes, Rinaldi Kusumawaty, Diah Emran, Talha Bin Yesiloglu, Talha Zahid Sippl, Wolfgang Mahmud, Shafi Alqahtani, Taha Alqahtani, Ali M. Asiri, Saeed Rahmatullah, Mohammed Jahan, Rownak Khan, Md. Arif Celik, Ismail Front Pharmacol Pharmacology The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as well as several other important parts of this virus, have recently undergone mutations, resulting in new virus variants. While no treatment is currently available, a naturally derived molecule with known antiviral properties could be used as a potential treatment. Bromelain is an enzyme found in the fruit and stem of pineapples. This substance has been shown to have a broad antiviral activity. In this article, we analyse the ability of bromelain to counteract various variants of the SARS-CoV-2 by targeting bromelain binding on the side of this viral interaction with human angiotensin-converting enzyme 2 (hACE2) using molecular docking and molecular dynamics simulation approaches. We have succeeded in making three-dimensional configurations of various RBD variants using protein modelling. Bromelain exhibited good binding affinity toward various variants of RBDs and binds right at the binding site between RBDs and hACE2. This result is also presented in the modelling between Bromelain, RBD, and hACE2. The molecular dynamics (MD) simulations study revealed significant stability of the bromelain and RBD proteins separately up to 100 ns with an RMSD value of 2 Å. Furthermore, despite increases in RMSD and changes in Rog values of complexes, which are likely due to some destabilized interactions between bromelain and RBD proteins, two proteins in each complex remained bonded, and the site where the two proteins bind remained unchanged. This finding indicated that bromelain could have an inhibitory effect on different SARS-CoV-2 variants, paving the way for a new SARS-CoV-2 inhibitor drug. However, more in vitro and in vivo research on this potential mechanism of action is required. Frontiers Media S.A. 2021-08-20 /pmc/articles/PMC8417730/ /pubmed/34489706 http://dx.doi.org/10.3389/fphar.2021.717757 Text en Copyright © 2021 Tallei, Fatimawali, Yelnetty, Idroes, Kusumawaty, Emran, Yesiloglu, Sippl, Mahmud, Alqahtani, Alqahtani, Asiri, Rahmatullah, Jahan, Khan and Celik. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Tallei, Trina Ekawati
Fatimawali,
Yelnetty, Afriza
Idroes, Rinaldi
Kusumawaty, Diah
Emran, Talha Bin
Yesiloglu, Talha Zahid
Sippl, Wolfgang
Mahmud, Shafi
Alqahtani, Taha
Alqahtani, Ali M.
Asiri, Saeed
Rahmatullah, Mohammed
Jahan, Rownak
Khan, Md. Arif
Celik, Ismail
An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
title An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
title_full An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
title_fullStr An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
title_full_unstemmed An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
title_short An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
title_sort analysis based on molecular docking and molecular dynamics simulation study of bromelain as anti-sars-cov-2 variants
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417730/
https://www.ncbi.nlm.nih.gov/pubmed/34489706
http://dx.doi.org/10.3389/fphar.2021.717757
work_keys_str_mv AT talleitrinaekawati ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT fatimawali ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT yelnettyafriza ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT idroesrinaldi ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT kusumawatydiah ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT emrantalhabin ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT yesiloglutalhazahid ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT sipplwolfgang ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT mahmudshafi ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT alqahtanitaha ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT alqahtanialim ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT asirisaeed ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT rahmatullahmohammed ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT jahanrownak ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT khanmdarif ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT celikismail ananalysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT talleitrinaekawati analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT fatimawali analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT yelnettyafriza analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT idroesrinaldi analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT kusumawatydiah analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT emrantalhabin analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT yesiloglutalhazahid analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT sipplwolfgang analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT mahmudshafi analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT alqahtanitaha analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT alqahtanialim analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT asirisaeed analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT rahmatullahmohammed analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT jahanrownak analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT khanmdarif analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants
AT celikismail analysisbasedonmoleculardockingandmoleculardynamicssimulationstudyofbromelainasantisarscov2variants